Navigation Links
NexGen Complete Knee Solution Legacy Knee Posterior Stabilized (LPS)

ProductsNexGen Complete Knee Solution Legacy Knee Posterior Stabilized (LPS)
Company Zimmer, Inc.
Item NexGen Complete Knee Solution Legacy Knee Posterior Stabilized (LPS)
Features The enhanced trochlear recess provides for a deeper patellar groove, which helps to improve patellofemoral contact. Compressive stress or pressure on the patella is reduced, helping to reduce forces which can lead to wear. This creates a smooth transition from flexion to extension.
Description The NexGen Legacy LPS Femoral Component is intended for patients who, in the surgeon's judgement, have adequate bone stock and varus/valgus stability, and/or when the surgeon elects to substitute for the posterior cruciate ligament. Fixation options include porous fiber metal, PMMA precoat and non-coated versions. These devices are for cemented use only.
Info Zimmer, Inc.
Customer Service: (800) 613-6131
Web site: http://www.zimmer.com

Related medicine products :

1. NexGen Complete Knee Solution Cruciate Retaining (CR)
2. NexGen Complete Knee Solution (CRA)
3. NexGen Complete Knee Solution Legacy Knee Constrained Condylar Knee (LCCK)
4. NexGen Complete Knee Solution IM Instrumentation
5. NexGen® Complete Knee Solution Cruciate Retaining (CR)
6. Complete MoisturePlus
7. Complete brand Blink-N-Clean Lens Drops
8. Troutman Punch Complete with 7- 9.0 mm piston and Teflon Block
9. Trouan Punch Complete with 7- 9.0 mm piston and Teflon Block
10. MEDPOR Complete Orbit Complex
11. Direct Focusing Headlight Complete
Other Medicine News:Health News:Streamline Health(R) Signs Catholic Healthcare West for Integrated Document Workflow Solutions 2Health News:Streamline Health(R) Signs Catholic Healthcare West for Integrated Document Workflow Solutions 3Health News:Streamline Health(R) Signs Catholic Healthcare West for Integrated Document Workflow Solutions 4Health News:CaringBridge(R) Enhances Web Service by Adding Printable CaringBook Option 2Health News:CaringBridge(R) Enhances Web Service by Adding Printable CaringBook Option 3Health News:Digirad Corporation Reports Financial Results for 2008 Second Quarter and Six Months 2Health News:Digirad Corporation Reports Financial Results for 2008 Second Quarter and Six Months 3Health News:Digirad Corporation Reports Financial Results for 2008 Second Quarter and Six Months 4Health News:Digirad Corporation Reports Financial Results for 2008 Second Quarter and Six Months 5Health News:Digirad Corporation Reports Financial Results for 2008 Second Quarter and Six Months 6Health News:Digirad Corporation Reports Financial Results for 2008 Second Quarter and Six Months 7Health News:Digirad Corporation Reports Financial Results for 2008 Second Quarter and Six Months 8Health News:Digirad Corporation Reports Financial Results for 2008 Second Quarter and Six Months 9Health News:Air Methods Provides 2nd Quarter Update and Date of Quarterly Conference Call 2Health News:Air Methods Provides 2nd Quarter Update and Date of Quarterly Conference Call 3Health News:Air Methods Provides 2nd Quarter Update and Date of Quarterly Conference Call 4Health News:Most Americans Don't Know 'Better Fats' Benefit Heart Health 2Health News:Most Americans Don't Know 'Better Fats' Benefit Heart Health 3Health News:Actress, Author Mariel Hemingway & Travelers Advantage Say: Treat Yourself To a Healthy Cruise 2Health News:Actress, Author Mariel Hemingway & Travelers Advantage Say: Treat Yourself To a Healthy Cruise 3
Breaking Medicine Technology:RetireSafe Announces Intention to Key Vote Senator Dorgan's Drug Importation Amendment (SA 2793) 2Dynatronics Receives 180-Day NASDAQ Extension 2Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 2Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 3Congressional Health Reform Bill Falls Short on Comprehensive and Affordable Coverage for Low Income Children 61194 1Congressional Health Reform Bill Falls Short on Comprehensive and Affordable Coverage for Low Income Children 61194 2Congressional Health Reform Bill Falls Short on Comprehensive and Affordable Coverage for Low Income Children 61194 3Dendreon Reports Third Quarter 2009 Financial Results and Continuing Progress Toward PROVENGE Commercialization 14801 1Dendreon Reports Third Quarter 2009 Financial Results and Continuing Progress Toward PROVENGE Commercialization 14801 2Dendreon Reports Third Quarter 2009 Financial Results and Continuing Progress Toward PROVENGE Commercialization 14801 3Dendreon Reports Third Quarter 2009 Financial Results and Continuing Progress Toward PROVENGE Commercialization 14801 4Dendreon Reports Third Quarter 2009 Financial Results and Continuing Progress Toward PROVENGE Commercialization 14801 5Dendreon Reports Third Quarter 2009 Financial Results and Continuing Progress Toward PROVENGE Commercialization 14801 6Dynatronics to Release First Quarter Results Friday November 13 2009 3B Conference Call Set for 1 3A30 p m ET 6188 1